While UROC1 was found to have a lower trend (0.05 < p < 0.1) in HCC-A group than HCC-AB (t = −1.669, DF =86, p = 0.099) group and HCC-NAF (t = −1.871, DF = 77, p = 0.065) group, CD5L was shown to have a lower trend (equal variances not assumed, t = −1.731, DF = 25.062, p = 0.096, 0.05 < p < 0.1) in HCC-A group than HCC-AC group. Here, CD5L is linked to hepatocellular carcinoma.